These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Monoclonal antibodies to endotoxin in the management of sepsis. Fang KC West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to endotoxin. New allies against sepsis? Bone RC JAMA; 1991 Aug; 266(8):1125-6. PubMed ID: 1865548 [No Abstract] [Full Text] [Related]
7. New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues. Quezado ZM; Banks SM; Natanson C Trends Biotechnol; 1995 Feb; 13(2):56-63. PubMed ID: 7765996 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies for gram-negative sepsis. Med Lett Drugs Ther; 1991 Nov; 33(856):103-4. PubMed ID: 1943976 [No Abstract] [Full Text] [Related]
9. [Anti-endotoxin monoclonal antibodies in the treatment of gram-negative germ sepsis]. Baumgartner JD Rev Prat; 1991 Jun; 41(16):1479-82. PubMed ID: 1853112 [No Abstract] [Full Text] [Related]
10. Therapies for sepsis. Emerging therapies for sepsis and septic shock. Abraham E West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195 [No Abstract] [Full Text] [Related]
11. Successful treatment of human gram-negative bacteremia with antiserum against endotoxin core. Ziegler EJ; McCutchan JA; Douglas H; Braude AI Trans Assoc Am Physicians; 1981; 94():39-43. PubMed ID: 7046193 [No Abstract] [Full Text] [Related]
16. Biotechnology. Go-ahead for Centocor. Gershon D Nature; 1991 Sep; 353(6340):101. PubMed ID: 1891035 [No Abstract] [Full Text] [Related]
17. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis]. van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630 [No Abstract] [Full Text] [Related]
18. An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody. Axtelle T; Pribble J J Endotoxin Res; 2003; 9(6):385-9. PubMed ID: 14733726 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody therapy for gram-negative sepsis: principles, applications, and controversies. Mehra IV; Gottlieb JE; Nash DB Pharmacotherapy; 1993; 13(2):128-34. PubMed ID: 8469619 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in the management of sepsis. Sikora JP Arch Immunol Ther Exp (Warsz); 2002; 50(5):317-24. PubMed ID: 12455865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]